CVS vs GRDN
CVS: A leading health solutions company integrating retail pharmacy, pharmacy benefit management, and insurance services to manage health costs and improve access to care. GRDN: Guardian Pharmacy Services provides specialized pharmacy and medication management solutions for long-term care facilities.
Side-by-side fundamentals
| Metric | CVS | GRDN | Edge |
|---|---|---|---|
| Price as of 2026-08-24 close | $94.11 | $37.70 | |
| Market cap as of 2026-08-24 | $120.4B | $2.4B | |
| P/E as of 2026-08-24 | 24.95 | 45.86 | CVS lower |
| PEG as of 2026-08-24 | 3.30 | n/a | |
| Net margin as of 2026-08-24 | +1.2% | +3.6% | GRDN higher |
| Gross margin as of 2026-08-24 | +14.2% | +20.9% | GRDN higher |
| Operating margin as of 2026-08-24 | +2.1% | +5.3% | GRDN higher |
| ROE as of 2026-08-24 | +6.4% | +27.2% | GRDN higher |
| ROA as of 2026-08-24 | +1.9% | +13.4% | GRDN higher |
| Debt / equity as of 2026-08-24 | 0.77 | 0.00 | GRDN lower |
| Revenue growth (YoY) as of 2026-08-24 | +7.4% | +11.3% | GRDN higher |
| Revenue CAGR (3y) SEC XBRL | +7.6% | n/a | |
| Dividend yield as of 2026-08-24 | +3.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-08-24 | 0.30 | 0.74 | |
| 1-year return as of 2026-08-24 close | +32.0% | +46.2% | GRDN higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.